Post by Oncode Accelerator

6,633 followers

๐—ช๐—ต๐—ฎ๐˜'๐˜€ ๐—ป๐—ฒ๐˜„ ๐—ถ๐—ป ๐—ฐ๐—ฎ๐—ป๐—ฐ๐—ฒ๐—ฟ ๐—ฟ๐—ฒ๐˜€๐—ฒ๐—ฎ๐—ฟ๐—ฐ๐—ต? With #ScienceFridays, we not only highlight exciting news fromย Oncode Accelerator, but also keep a close eye on interesting cancer research news from around the world. In this week's carousel, read about... ๐Ÿ’กย ๏ปฟโ€œArmoredโ€ CAR-T Cellย ๏ปฟTherapy To Target Antigen-Heterogeneous Gliomaย ๐Ÿ‘‰ย https://lnkd.in/e3PT8vpH๏ปฟ ๐Ÿ’กTheย Worldโ€™s First Approvedย ๏ปฟCAR-T Therapy for Solid Tumorsย ๏ปฟ๐Ÿ‘‰ย https://lnkd.in/eFBSfPcw ๐Ÿ’ก๏ปฟClosing the Valley of Death: The Infrastructure Gap Holding Back Early-Stage Biologics Programsย ๐Ÿ‘‰ย https://lnkd.in/ezMkbTt2 ๐Ÿ‘‰ Follow Oncode Accelerator for more content like this. Debby Vermeer-Kruijsen, Ph.D., Richard Van Rijnsoever #cancerresearch #CART #antibodytherapy

Post contentPost contentPost content